Recombinant human GM-CSF GMP protein, CF and recombinant human IFN-gamma GMP protein, CF r & d systems INC:1107462 [25-008672]
Ended Awarded Last action
- Contract number
- 75N90025F00001
- Awardee
-
Research And Diagnostic Systems, Inc. UEI WAYSQU5HJYT9
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,880
Award facts
- Contract value 100% obligated
- $12,879.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Minneapolis, MN 55413, USA
Award details come from SAM.gov/FPDS.
About this award
Research and Diagnostic Systems, Inc., doing business as R&D Systems, was awarded a $12,879.50 firm fixed-price blanket purchase agreement (BPA) call by the NIH Clinical Center on August 31, 2025, for the delivery of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) GMP protein and recombinant human interferon-gamma (IFN-gamma) GMP protein. The contract is scheduled for completion on September 30, 2025, and represents a non-set-aside purchase made under open competition. R&D Systems, a Minneapolis-based manufacturer of biological research materials and a subsidiary of Bio-Techne Corporation, will perform the work at its facility in Minneapolis, Minnesota.
This award is executed under R&D Systems' existing $10 million blanket purchase agreement with the Office of Logistics and Acquisition Operations through September 30, 2025. The company has established itself as a critical supplier to the NIH ecosystem, providing specialized proteins, antibodies, reagents, and laboratory supplies that support biomedical research across multiple institutes and centers. The recombinant proteins delivered under this task order are essential research materials used in immunological and translational science studies, consistent with R&D Systems' portfolio of high-quality biologics supporting federal research priorities.
Quick answers
Who was awarded contract 75N90025F00001?
75N90025F00001 was awarded to Research And Diagnostic Systems, Inc. by NIH Clinical Center (National Institutes of Health) on August 31, 2025.
How much is contract 75N90025F00001 worth?
The government has obligated $12,880 on 75N90025F00001.
Is contract 75N90025F00001 an order under another contract?
Yes. 75N90025F00001 is a BPA call under 75N98025A00009, a blanket purchase agreement.
Was contract 75N90025F00001 competed?
The extent of competition for 75N90025F00001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award